Information for schools and early childhood education/care

Supply update - EpiPen® Jr 

Mylan Australia has advised that there is sufficient supply of EpiPen® Jr 150 microgram adrenaline (epinephrine) autoinjectors at wholesalers and at Mylan’s warehouse to meet current patient needs in Australia.

Orders from wholesalers and pharmacies are being filled as they are received. As a result, EpiPen® Jr has been removed from the Therapeutic Goods Administration (TGA) Medicines Shortage Information Initiative website. Mylan Australia’s dedicated, toll-free EpiPen Customer Service hotline 1800 931 625 remains up and running for any enquiries. 

Anaphylaxis resources

ASCIA anaphylaixs resources (including action plans, e-training courses and guidelines) are used throughout Australasian schools and early childhood education/care services. These resources are available at 

Anaphylaxis e-training for schools and early childhood education/care  

Anaphylaxis resources - including action plans and instructional videos 

Anaphylaxis management guidelines  

Risk minimisation strategies for schools, preschools and and early childhood education/care

pdfASCIA Risk minimisation strategies March 20151.13 MB

250K youth project resources 

Slide set - are you allergy aware?

Primary School

Slide set primary schools - are you allergy aware?

pdfAllergy Aware presentation primary school654.75 KB

Secondary School

Slide set secondary schools - are you allergy aware?

pdfAllergy Aware presentation secondary school699.66 KB

Patient support organisations 

Food Allergy Xplained – interactive information resource for teenagers

 Content updated February 2020

Mod ASCIA Member
Donate to AIFA
go to NAS website
Member Login
ASCIA Update

Information for the community about allergic diseases, immunodeficiencies and other immune diseases.
See latest edition here...
Join our mailing list:


ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: verify here.